<?xml version="1.0" encoding="UTF-8"?>
<fig id="F0008" orientation="portrait" position="float">
 <label>Figure 8.</label>
 <caption>
  <p>% Glucose level inhibition of sitagliptin and dapagliflozin from normal control, diabetic (STZ) control, diabetic (STZ) + THQ, diabetic (STZ) + DN, diabetic (STZ) + SN, diabetic (STZ) + DN + SN (F1-SNEDDS-BSO/CMCM/CrEL [15/35/50] %w/w combined dose), diabetic (STZ) + marketed drug. STZ: streptozotocin; SN: sitagliptin; DN: dapagliflozin; THQ: thymoquinone. Data are presented as (Mean ± SEM, 
   <italic>n</italic> = 3).
  </p>
 </caption>
 <graphic content-type="black-white" xlink:href="IDRD_A_1859001_F0008_B" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</fig>
